A sharper eye on breast cancer: new scan spots key protein
NCT ID NCT07292571
First seen Jan 06, 2026 · Last updated May 20, 2026 · Updated 18 times
Summary
This study tests a special radioactive tracer that binds to HER2, a protein on some breast cancer cells. By using SPECT/CT scans, doctors hope to see how much HER2 is in the tumor without needing a biopsy. The study involves 50 adults with breast cancer and aims to improve how we identify which patients might benefit from targeted therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences
Tomsk, Russia
Conditions
Explore the condition pages connected to this study.